Telmisartan 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FWCAW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,138
Award facts
- Contract value 100% obligated
- $1,137.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,137.56 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical supply agreement with the DLA. The SPE2DX contract vehicle enables the company to supply a broad spectrum of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. This telmisartan procurement exemplifies the routine pharmaceutical deliveries executed under the larger prime vendor agreement, supporting ongoing medical supply chain requirements for federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWCAW?
SPE2DB25FWCAW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FWCAW worth?
The government has obligated $1,138 on SPE2DB25FWCAW.
Is contract SPE2DB25FWCAW an order under another contract?
Yes. SPE2DB25FWCAW is a delivery order under SPE2DB25D3022, an indefinite delivery contract.
Was contract SPE2DB25FWCAW competed?
The extent of competition for SPE2DB25FWCAW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award